Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort (CERBois)

August 25, 2016 updated by: Central Hospital, Nancy, France

Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort. Feasibility Evaluation

The purpose is to evaluate feasibility of medical supervision of professionally active asymptomatic wood workers with questionnaires and nasofibroscopy.

Secondary purposes are:

  • Feasibility evaluation of identification of former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics in case of co-expositions (formaldehyde, chrome, nickel, leather)
  • Description of abnormal symptoms identified by occupational doctor and needing an otorhinolaryngology test
  • Description of results and examinations induced by nasofibroscopy in symptomatic or asymptomatic individuals: counting of naso-sinusal adenocarcinoma cases
  • Evaluation of participation of workers retiring in 2 years after inclusion to medical supervision program
  • Evaluation of information flow among different players
  • Assessment of costs induced by this targeted screening: direct medical costs (screened pathologies, induced additional examinations…) and indirect costs for company (duration of worker absence for transfer, medical and additional examinations).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France
        • AHI 33
      • Lille, France
        • Pôle Santé Travail
      • Paris, France
        • Gnmst-Btp
      • Paris, France
        • Ville de Paris
      • Suresnes, France
        • ACMS
      • Vandoeuvre Les Nancy, France
        • Centres de Consultations de Pathologies Professionnelles

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

44 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Population under analysis consists of all workers seen in occupational health consultation and exposed to wood dust at least for cumulated 12 months and with first exposition back to more than 30 years

Description

Inclusion Criteria:

  • Employee or craftsman
  • Actual or former professional exposition to wood dust
  • Onset of exposition to wood dust back to more than 30 years (latency >30 years)
  • Cumulated exposition to wood dust longer than 12 months
  • Exposition to wood dust during machining tasks (sawing, milling, planing, drilling, bridging) or all documented activities exposing to wood dust concentration > 1 mg/m3 for 8 hours
  • Worker followed by occupational doctor of participant occupational health departments
  • Worker accepting medico-professional supervision recommended by guidelines
  • Affiliation to social security

Exclusion Criteria:

  • Difficulty with comprehension of wood auto-questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Workers exposed to wood dust

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: Day 0
Day 0
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 3 months
3 months
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 24 months
24 months
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 27 months
27 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics
Time Frame: Day 0
Day 0
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time Frame: Day 0
Day 0
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time Frame: 24 months
24 months
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time Frame: 3 months
3 months
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time Frame: 27 months
27 months
Participation to medical supervision program of workers retiring in 2 years after inclusion
Time Frame: Day 0
Day 0
Evaluation of information flow among different players
Time Frame: 3 months
3 months
Evaluation of information flow among different players
Time Frame: 27 months
27 months
Medical costs Induced by screening
Time Frame: 3 months
3 months
Medical costs Induced by screening
Time Frame: 27 months
27 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christophe PARIS, Pr, Centre de Consultations de Pathologies Professionnelles - Hôpitaux de Brabois - CHU de Nancy - France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

August 23, 2016

First Submitted That Met QC Criteria

August 25, 2016

First Posted (Estimate)

August 30, 2016

Study Record Updates

Last Update Posted (Estimate)

August 30, 2016

Last Update Submitted That Met QC Criteria

August 25, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2011/INCA/CERBOIS/PARIS-HERIN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exposition to Wood Dust

Clinical Trials on Nasofibroscopy

Subscribe